Back to Search
Start Over
A phase II, multicenter, open-label study of abemaciclib and letrozole in patients with estrogen receptor-positive rare ovarian cancer: ALEPRO trial.
- Source :
- International Journal of Gynecological Cancer; Apr2024, Vol. 34 Issue 4, p627-630, 4p
- Publication Year :
- 2024
Details
- Language :
- English
- ISSN :
- 1048891X
- Volume :
- 34
- Issue :
- 4
- Database :
- Supplemental Index
- Journal :
- International Journal of Gynecological Cancer
- Publication Type :
- Academic Journal
- Accession number :
- 177174625
- Full Text :
- https://doi.org/10.1136/ijgc-2023-005189